Jun-xiang Li
Guiyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
High Fibroblast Activation Protein Expression in Hepatocellular Carcinoma: CT Imaging Features and Histological Characteristics.
Journal: Academic radiology
Published: March 04, 2025
Skeletal muscle index/systemic immune-inflammation index (SMI/SII) ratio predicts prognosis in patients with hepatocellular carcinoma.
Journal: World journal of surgical oncology
Published: February 14, 2025
An Integrated Liver Function, Systemic Inflammation, and Tumor Characteristic Score Predicts Prognosis in Hepatocellular Carcinoma After Curative Resection.
Journal: Annals of surgical oncology
Published: September 28, 2022
Liver resection versus microwave ablation for hepatocellular carcinoma in ideal candidates for ablation per Barcelona Clinic Liver Cancer staging: a propensity score matching and inverse probability of treatment weighting analysis.
Journal: Alimentary pharmacology & therapeutics
Published: August 27, 2022
Ideal patients for liver resection in Barcelona Clinic Liver Cancer or Hong Kong Liver clinic systems for hepatocellular carcinoma: Conservative or aggressive?
Journal: Frontiers in medicine
Published: June 24, 2022
Tumor enhancement ratio with unenhanced imaging is an independent prognostic factor for patients with hepatocellular carcinoma after transarterial chemoembolization.
Journal: The Journal of international medical research
Published: November 23, 2021
Chemoembolization Plus Microwave Ablation vs Chemoembolization Alone in Unresectable Hepatocellular Carcinoma Beyond the Milan Criteria: A Propensity Scoring Matching Study.
Journal: Journal of hepatocellular carcinoma
Published: September 13, 2021
Predicting early refractoriness of transarterial chemoembolization in patients with hepatocellular carcinoma using a random forest algorithm: A pilot study.
Journal: Journal of Cancer
Published: May 31, 2021
Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE.
Journal: Risk management and healthcare policy
Published: April 21, 2021
Integrated Liver Inflammatory Score Predicts the Therapeutic Outcome of Patients with Hepatocellular Carcinoma after Transarterial Chemoembolization.
Journal: Journal of vascular and interventional radiology : JVIR
Published: December 07, 2020
Last Updated: 09/26/2026